THE JAK2 V617F MUTATION IS PRESENT IN A MINORITY OF HUMAN HEMATOPOIETIC STEM CELLS FROM PATIENTS WITH MYELOPROLIFERATIVE DISORDERS AND DOES NOT MODIFY THEIR SELF-RENEWAL PROPERTIES
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
